These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 19337958

  • 1. MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.
    Stovall DW, Pinkerton JV.
    Curr Opin Investig Drugs; 2009 Apr; 10(4):365-71. PubMed ID: 19337958
    [Abstract] [Full Text] [Related]

  • 2. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.
    Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Granger AL, Fehnel SE, Levine KB, Jordan J, Clark RV.
    Climacteric; 2008 Feb; 11(1):32-43. PubMed ID: 18202963
    [Abstract] [Full Text] [Related]

  • 3. Use of a multibotanical (Nutrafem) for the relief of menopausal vasomotor symptoms: a double-blind, placebo-controlled study.
    Garcia JT, Gonzaga F, Tan D, Ng TY, Oei PL, Chan CW.
    Menopause; 2010 Mar; 17(2):303-8. PubMed ID: 19934777
    [Abstract] [Full Text] [Related]

  • 4. MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms.
    Leitman DC, Christians U.
    Expert Opin Investig Drugs; 2012 Jul; 21(7):1031-42. PubMed ID: 22616988
    [Abstract] [Full Text] [Related]

  • 5. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society.
    Menopause; 2004 Jul; 11(1):11-33. PubMed ID: 14716179
    [Abstract] [Full Text] [Related]

  • 6. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
    Wang PH, Horng HC, Cheng MH, Chao HT, Chao KC.
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):127-34. PubMed ID: 17638620
    [Abstract] [Full Text] [Related]

  • 7. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.
    Kwee SH, Tan HH, Marsman A, Wauters C.
    Maturitas; 2007 Sep 20; 58(1):83-90. PubMed ID: 17689896
    [Abstract] [Full Text] [Related]

  • 8. A 12-week clinical trial determining the efficacy of synthetic conjugated estrogens, A (SCE), in the treatment of vasomotor symptoms in menopausal women.
    Stevens RE, Hanford K, Wason S, Cusack SL, Phelps KV.
    Int J Fertil Womens Med; 2000 Sep 20; 45(4):264-72. PubMed ID: 10997482
    [Abstract] [Full Text] [Related]

  • 9. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.
    Soares CN, Arsenio H, Joffe H, Bankier B, Cassano P, Petrillo LF, Cohen LS.
    Menopause; 2006 Sep 20; 13(5):780-6. PubMed ID: 16894334
    [Abstract] [Full Text] [Related]

  • 10. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Sep 20; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 11. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG, Drosman S, Helmond FA, Stathopoulos VM.
    Menopause; 2006 Sep 20; 13(6):917-25. PubMed ID: 17006377
    [Abstract] [Full Text] [Related]

  • 12. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K.
    Menopause; 2008 Sep 20; 15(1):51-8. PubMed ID: 18257142
    [Abstract] [Full Text] [Related]

  • 13. The effectiveness of sublingual and topical compounded bioidentical hormone replacement therapy in postmenopausal women: an observational cohort study.
    Ruiz AD, Daniels KR.
    Int J Pharm Compd; 2014 Sep 20; 18(1):70-7. PubMed ID: 24881343
    [Abstract] [Full Text] [Related]

  • 14. The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety.
    Stovall DW, Utian WH, Gass ML, Qu Y, Muram D, Wong M, Plouffe L.
    Menopause; 2007 Sep 20; 14(3 Pt 1):510-7. PubMed ID: 17314736
    [Abstract] [Full Text] [Related]

  • 15. Estrogen receptor beta and its selective ligands: an option for treatment of menopausal vasomotor symptoms?
    Jarry H.
    Horm Mol Biol Clin Investig; 2013 Dec 20; 16(1):7-12. PubMed ID: 25436742
    [Abstract] [Full Text] [Related]

  • 16. Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.
    Pinkerton JV, Stovall DW.
    Expert Opin Investig Drugs; 2010 Dec 20; 19(12):1613-21. PubMed ID: 21073353
    [Abstract] [Full Text] [Related]

  • 17. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH.
    Health Qual Life Outcomes; 2005 Aug 05; 3():47. PubMed ID: 16083502
    [Abstract] [Full Text] [Related]

  • 18. Novel ligands balance estrogen receptor β and α agonism for safe and effective suppression of the vasomotor response in the ovariectomized female rat model of menopause.
    McGregor C, Sau A, Ruddy SC, Leung D, Webb M, Durst T, Wright JS, Lagace D, Pratt MA.
    Endocrinology; 2014 Jul 05; 155(7):2480-91. PubMed ID: 24823389
    [Abstract] [Full Text] [Related]

  • 19. MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial.
    Grady D, Sawaya GF, Johnson KC, Koltun W, Hess R, Vittinghoff E, Kristof M, Tagliaferri M, Cohen I, Ensrud KE.
    Menopause; 2009 Jul 05; 16(3):458-65. PubMed ID: 19182698
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women.
    Wang CC, Cheng KF, Lo WM, Law C, Li L, Leung PC, Chung TK, Haines CJ.
    Menopause; 2013 Feb 05; 20(2):223-31. PubMed ID: 22990757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.